Process development of clinical anti-HBV drug Y101: identification and synthesis of novel impurities
暂无分享,去创建一个
W. Pan | Changxiao Liu | Bixue Xu | Guang-yi Liang | Wen Xia | Zheng-ming Huang | Zhan-xing Hu | Hai-Ping Liao | Q. An | Pei-xue Cao
暂无分享,去创建一个
W. Pan | Changxiao Liu | Bixue Xu | Guang-yi Liang | Wen Xia | Zheng-ming Huang | Zhan-xing Hu | Hai-Ping Liao | Q. An | Pei-xue Cao